Patent Assignment
Reel/Frame 040962/0651
Assignment of Assignor's Interest
Recorded: 2017-01-16
Pages: 11
Assignor
XCYTE THERAPIES, INC.
Executed: 2005-12-14
Assignee
INVITROGEN CORPORATION
5791 VAN ALLEN WAY, CARLSBAD, CALIFORNIA, 92008
Covered Property
(1)
Methods for Eliminating at Least a Substantial Portion of a Clonal Antigen-Specific Memory T Cell Subpopulation
Application:
15/354,241 →
Publication:
US 2017/0114321
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 16, 2017
From: BERENSON, RONALD J.; BONYHADI, MARK; KALAMASZ, DALE
To: XCYTE THERAPIES, INC
Reel/Frame 040962/0477 →
Merger and Change of Name
Jan 16, 2017
From: INVITROGEN CORPORATION; LIFE TECHNOLOGIES CORPORATION
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 040962/0681 →